Kellerman Donald J's Form 4 filing
Zosano Pharma Corp (ZSAN) · filed Apr 1, 2022
- Accession no.
- 0001567619-22-007910
- Filed
- Apr 1, 2022, 9:08 PM ET
- Trade date
- Mar 31, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $841.66. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kellerman Donald JCIK 0001145911 | Officer (VP, Clinical Dev & Med Affairs) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | Common Stock | SSaleDisposed | −4,006 | $0.2101 | −$841.66 | 56,331 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.